Format

Send to

Choose Destination
J Clin Neurosci. 2019 Feb;60:31-35. doi: 10.1016/j.jocn.2018.10.001. Epub 2018 Oct 24.

2016-2017 clinical trials in cerebrovascular neurosurgery.

Author information

1
Department of Medicine, Olive View-UCLA Medical Center, David Geffen School of Medicine at UCLA, 14445 Olive View Drive, Sylmar, CA, United States.
2
Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, United States. Electronic address: rdu@bwh.harvard.edu.

Abstract

Several clinical trials in cerebrovascular neurosurgery were published during 2016-2017. The Collaborative Unruptured Endovascular versus Surgery Trial (CURES) found no difference in outcome between clipping versus coiling of unruptured aneurysms after one year. The Flow Diversion in the Treatment of Intracranial Aneurysm Trial (FIAT) was terminated due to safety concerns. Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity after Subarachnoid Hemorrhage Trial (NEWTON) and other trials demonstrated no improvement in outcome for vasospasm. The Duration of Prophylaxis after Subarachnoid Hemorrhage Trial (DOPAST) did not show benefit for extended seizure prophylaxis. Minimally Invasive Surgery plus Alteplase in Intracerebral Hemorrhage Evacuation Trial (MISTIE) reported a new strategy for treating intracerebral hemorrhage. A hemorrage site analysis from the Japan Adult Moyamoya Trial (JAM) was presented. The 10-year results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) and the new Asymptomatic Carotid Trial I (ACT I) were reported. Lastly, findings from six ischemic stroke trials were presented.

KEYWORDS:

Aneurysm; Carotid stenosis; Intracerebral hemorrhage; Ischemic stroke; Moyamoya; Subarachnoid hemorrhage

PMID:
30626525
DOI:
10.1016/j.jocn.2018.10.001

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center